Naty Saidoff and Moti Ben-Moshe further have improved their bids in recent days ahead of tomorrow's decisive vote by the company's bondholders.
The company lost 90% of its value since its IPO.
Many of the company's employees are programmers from the haredi sector.
The Tel Aviv company has developed GPS technology providing high-accuracy solutions for autonomous and connected vehicle applications.
Cell Design Labs was sponsored by Arie Belldegrun, founder of Kite Pharma, which Gilead acquired for $12 billion.
Argus's CEO and CMO talk about their competitive advantage and how they might expand from car cybersecurity.
Prof. Gideon Gross is suing Prof. Zelig Eshhar, alleging that Eshhar cheated him out of his share of the $11.9 billion sale of Kite, which has developed a revolutionary cancer drug.
More energetic than ever, Arie Belldegrun talks to "Globes" about Kite Pharma's remarkable journey and the future of cancer treatment.
Accelmed seeks to replicate its success formula in urology, as portfolio company Cogentix makes a third acquisition.